These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36884286)

  • 1. Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model.
    Fraticelli L; Freyssenge J; Promé-Combel E; Agnellet E; Dargaud Y; Chamouard V
    JMIR Res Protoc; 2023 Mar; 12():e43091. PubMed ID: 36884286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data.
    Winslade N; Tamblyn R
    BMJ Open; 2017 Sep; 7(9):e015877. PubMed ID: 28939571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effects of a drug with fiscalized substance dispensation, health education, and pharmacovigilance continuing education program in Colombia drugstores and drugstores/pharmacies: study protocol of a multicenter, cluster-randomized controlled trial.
    Ceballos M; Salazar-Ospina A; Sabater-Hernández D; Amariles P
    Trials; 2020 Jun; 21(1):545. PubMed ID: 32560735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019.
    Tofighi B; Lekas HM; Williams SZ; Martino D; Blau C; Lewis CF
    J Subst Abuse Treat; 2021 Oct; 129():108372. PubMed ID: 34080543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmaceutical regulations in Chad: assessment of drug dispensing practices in private pharmacies in N'Djamena].
    Gueralbaye LO; Zongo L; Zongo RFE; Mahamat HB; Ouédraogo A; Avocksouma DA
    Pan Afr Med J; 2023; 44():16. PubMed ID: 37013218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of why some community pharmacists do not provide 72-hour emergency prescription drugs to Medicaid patients when prior authorization is not available.
    Shepherd MD
    J Manag Care Pharm; 2013 Sep; 19(7):523-33. PubMed ID: 23964613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dispensing practice in the community pharmacies in the Turkish Republic of Northern Cyprus.
    Gokcekus L; Toklu HZ; Demirdamar R; Gumusel B
    Int J Clin Pharm; 2012 Apr; 34(2):312-24. PubMed ID: 22262499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Collaborative Protocolized Approach by Community Pharmacists and General Medical Practitioners for an Australian Minor Ailments Scheme: Protocol for a Cluster Randomized Controlled Trial.
    Dineen-Griffin S; Garcia-Cardenas V; Rogers K; Williams K; Benrimoj SI
    JMIR Res Protoc; 2019 Aug; 8(8):e13973. PubMed ID: 31400107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of costs to dispense prescriptions in independently owned, closed-door long-term care pharmacies.
    Carroll NV; Rupp MT; Holdford DA
    J Manag Care Spec Pharm; 2014 Mar; 20(3):291-300. PubMed ID: 24564809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-dispensing problems community pharmacists face when patients are discharged from hospitals: a study about 537 prescriptions in Alsace.
    Michel B; Hemery M; Rybarczyk-Vigouret MC; Wehrlé P; Beck M
    Int J Qual Health Care; 2016 Dec; 28(6):779-784. PubMed ID: 27655792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke patients' support: evaluation of knowledge, practices and training needs of French community pharmacists.
    Khettar S; Viprey M; Haesebaert J; Jacquin-Courtois S; Luauté J; Mechtouff L; Derex L; Rode G; Dussart C; Janoly-Dumenil A
    Int J Clin Pharm; 2021 Aug; 43(4):980-989. PubMed ID: 33387187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the appropriateness of a community pharmacy model for a colorectal cancer screening program in Catalonia (Spain).
    Santolaya M; Aldea M; Grau J; Estrada M; Barau M; Buron A; Francesc M; Castell A; Rodriguez C; Gascón P; Rius P; Guayta-Escolies R;
    J Oncol Pharm Pract; 2017 Jan; 23(1):26-32. PubMed ID: 26563130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing maintenance dosing of emicizumab-kxwh as prophylaxis in hemophilia A: Dosing to product labeling while minimizing drug waste.
    D'Albini L; Dorholt M; Gallucci L
    J Manag Care Spec Pharm; 2023 Jan; 29(1):47-57. PubMed ID: 36580124
    [No Abstract]   [Full Text] [Related]  

  • 16. What drives inappropriate antibiotic dispensing? A mixed-methods study of pharmacy employee perspectives in Haryana, India.
    Barker AK; Brown K; Ahsan M; Sengupta S; Safdar N
    BMJ Open; 2017 Mar; 7(3):e013190. PubMed ID: 28255093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.
    Rudolph SE; Branham AR; Rhodes LA; Hayes HH; Moose JS; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S55-S58.e3. PubMed ID: 30006187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies.
    Ross-Degnan D; Soumerai SB; Goel PK; Bates J; Makhulo J; Dondi N; Sutoto ; Adi D; Ferraz-Tabor L; Hogan R
    Health Policy Plan; 1996 Sep; 11(3):308-18. PubMed ID: 10160376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety analysis of rFVIIa with emicizumab dosing in congenital hemophilia A with inhibitors: Experience from the HAVEN clinical program.
    Levy GG; Asikanius E; Kuebler P; Benchikh El Fegoun S; Esbjerg S; Seremetis S
    J Thromb Haemost; 2019 Sep; 17(9):1470-1477. PubMed ID: 31124272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migraine management in community pharmacies: practice patterns and knowledge of pharmacy personnel in Thailand.
    Saengcharoen W; Lerkiatbundit S
    Headache; 2013 Oct; 53(9):1451-63. PubMed ID: 23808927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.